Skip to main content

Table 3 Analysis for joint preservation

From: Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study

N = 95

Joint status after final surgery

Chi-square analysis

Logistic analysis

Preserve

Sacrifice

P value

X2 value

Standardized coefficient (B)

Relative risk (eB)

95 % CI

P value

Age grade

≤ 35

50

12

      

> 35

22

10

0.197

1.666

0.934

2.546

0.853–7.600

0.094

Gender

F

37

8

      

M

35

14

0.217

1.524

0.575

1.777

0.606–5.209

0.295

Patient status

Group P

67

17

      

Group R

5

5

0.036

4.415

0.987

2.683

0.548–13.139

0.223

Campanacci Grade

I or II

62

14

      

III

10

8

0.019

5.498

1.172

3.230

0.957–10.903

0.059

Recurrence type

Repetitive

19

9

0.0192

1.699

0.475

0.622

0.200–1.930

0.411

Single

53

13